Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $75.7000 (-1.3%) ($73.8100 - $76.8400) on Mon. Jun. 3, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.06% (three month average) | RSI | 49 | Latest Price | $75.7000(-1.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1.1% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.1% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(60%) DIA(50%) VYM(50%) IVE(49%) SPLV(49%) | Factors Impacting ABBV price | ABBV will decline at least -0.53% in a week (0% probabilities). VXX(-15%) TLT(-15%) IFRA(-11%) IGOV(-3%) UUP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.53% (StdDev 1.06%) | Hourly BBV | 0 () | Intraday Trend | -1.2% | | | |
|
Resistance Level | $78.65 | 5 Day Moving Average | $77.2(-1.94%) | 10 Day Moving Average | $78.85(-3.99%) | 20 Day Moving Average | $78.65(-3.75%) | To recent high | -9.9% | To recent low | 0% | Market Cap | $133.556b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |